本页面由Tiger Trade Technology Pte. Ltd.提供服务

Akebia Therapeutics, Inc.

0.7700
-0.0202-2.56%
盘后:0.77400.0040+0.52%19:58 EDT
成交量:649.81万
成交额:510.17万
市值:2.13亿
市盈率:-6.92
高:0.8049
开:0.8000
低:0.7655
收:0.7902
52周最高:3.20
52周最低:0.7655
股本:2.77亿
流通股本:2.69亿
量比:0.86
换手率:2.41%
股息:- -
股息率:- -
每股收益(TTM):-0.1112
每股收益(LYR):-0.0208
净资产收益率:-109.38%
总资产收益率:-1.05%
市净率:8.53
市盈率(LYR):-37.05

数据加载中...

2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/18

重要事件披露

Form 8-K - Current report